1.26
price down icon3.08%   -0.04
after-market After Hours: 1.29 0.03 +2.38%
loading

Gossamer Bio Inc Stock (GOSS) Latest News

pulisher
Feb 24, 2025

You Should Read This Analysis Before Investing in Gossamer Bio Inc (NASDAQ:GOSS) - US Post News

Feb 24, 2025
pulisher
Feb 24, 2025

Gossamer Bio Inc (NASDAQ: GOSS) Up 11.11% This Year: What Is Going To Happen Next - Stocks Register

Feb 24, 2025
pulisher
Feb 19, 2025

Gossamer Bio regains Nasdaq compliance with bid price - Investing.com

Feb 19, 2025
pulisher
Feb 13, 2025

Gossamer Bio Is A Good Speculative 'Buy' On Seralutinib For PAH And PH-ILD (NASDAQ:GOSS) - Seeking Alpha

Feb 13, 2025
pulisher
Feb 11, 2025

Understanding Gossamer Bio Inc Inc. (GOSS) Price Performance Through Chart Patterns - The InvestChronicle

Feb 11, 2025
pulisher
Feb 07, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Feb 07, 2025
pulisher
Feb 07, 2025

GOSS Stock Sees Surge of Approximately 15.18% in Last Five Days - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Gossamer Bio Inc (NASDAQ: GOSS) Stock Gained 1.83% Over A Month – Any Room To Run? - Marketing Sentinel

Feb 07, 2025
pulisher
Feb 07, 2025

Gossamer Bio showcases seralutinib studies at PVRI Congress - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Insider Alert: Gossamer Bio Awards Massive Stock Options Package Worth $586,500 - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Gossamer Bio Inc (GOSS) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Gossamer Bio Inc (GOSS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Feb 06, 2025
pulisher
Feb 05, 2025

Octagon Capital Advisors LP Increases Stake in Gossamer Bio Inc - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Real-Time Update: Gossamer Bio Inc (GOSS) Stock Navigates the Market with Up-to-Date Data - The News Heater

Feb 05, 2025
pulisher
Feb 05, 2025

Investor’s Delight: Gossamer Bio Inc (GOSS) Closes Weak at 1.02, Down -0.97 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH - Managed Healthcare Executive

Feb 05, 2025
pulisher
Feb 04, 2025

Gossamer Bio (NASDAQ:GOSS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Analysts Offer Predictions for Gossamer Bio FY2029 Earnings - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire

Feb 03, 2025
pulisher
Feb 02, 2025

Gossamer Bio’s (GOSS) “Buy” Rating Reiterated at HC Wainwright - Defense World

Feb 02, 2025
pulisher
Feb 02, 2025

HC Wainwright Weighs in on Gossamer Bio FY2029 Earnings - Defense World

Feb 02, 2025
pulisher
Jan 31, 2025

Vanguard Group Inc Reduces Stake in Gossamer Bio Inc - GuruFocus.com

Jan 31, 2025
pulisher
Jan 30, 2025

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges - Simply Wall St

Jan 30, 2025
pulisher
Jan 28, 2025

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire

Jan 28, 2025
pulisher
Jan 28, 2025

Game-Changing PAH Treatment Combo Shows Powerful Synergistic Effects in Latest Clinical Data - StockTitan

Jan 28, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Estimates Gossamer Bio FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Brokers Set Expectations for Gossamer Bio FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 20, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 12.8% in December - MarketBeat

Jan 20, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 08, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by Geode Capital Management LLC - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

Gossamer Bio Grants 225,000 Stock Options to New Employees in Retention Push - StockTitan

Jan 07, 2025
pulisher
Jan 06, 2025

12 Best Penny Stocks to Invest in According to the Media - Insider Monkey

Jan 06, 2025
pulisher
Jan 01, 2025

3 US Penny Stocks With Market Caps Over $100M - Simply Wall St

Jan 01, 2025
pulisher
Dec 31, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Sees Large Increase in Short Interest - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Up 10.0% in December - Defense World

Dec 31, 2024
pulisher
Dec 26, 2024

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know - MSN

Dec 26, 2024
pulisher
Dec 16, 2024

The Manufacturers Life Insurance Company Boosts Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Dec 16, 2024
pulisher
Dec 13, 2024

Biggest stock gainers and losers on Thursday - The Africa Logistics

Dec 13, 2024
pulisher
Dec 03, 2024

US Penny Stocks: 3 Picks With Market Caps Under $200M - Simply Wall St

Dec 03, 2024
pulisher
Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio - The Manila Times

Dec 02, 2024
pulisher
Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the - GlobeNewswire

Dec 02, 2024
pulisher
Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20M, Adds Phase 3 PAH Drug to Portfolio - StockTitan

Dec 02, 2024
pulisher
Nov 29, 2024

Gossamer Bio: Q3 Earnings Snapshot - Marketscreener.com

Nov 29, 2024
pulisher
Nov 26, 2024

Adicet Bio Inc (NASDAQ: ACET) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register

Nov 26, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Invests $67,000 in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Nov 26, 2024
pulisher
Nov 25, 2024

Gossamer Bio Inc (GOSS)Monday, Aug 26, 2024 - Smartkarma

Nov 25, 2024
pulisher
Nov 22, 2024

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy - MSN

Nov 22, 2024
pulisher
Nov 19, 2024

US Bancorp DE Makes New $39,000 Investment in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Nov 19, 2024
pulisher
Nov 15, 2024

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance

Nov 15, 2024
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):